The European Commission’s work to secure access to potential COVID-19 vaccines is welcome, but other therapies are needed to end the pandemic and negotiations with European manufacturers of anti-viral antibodies should not be further delayed

Data from Germany and UK show BioNTech and AstraZeneca vaccines induce a broad immune response in early trials. Meanwhile UK government continues to go it alone in striking advance purchase deals

MEP calls for access to research data before EU makes vaccine bets with €2.3B advance purchase fund

Brussels will negotiate advance purchase agreements, giving manufacturers confidence to invest before they know if vaccines work, and ensuring equitable access for EU27 and low- and middle-income countries around the world

Brussels aims to head off competition between EU states for vaccines, and de-risk investment in research and manufacturing for companies

Europe needs to be better prepared for future pandemics, according to letter from six member states

‘Everyone who needs the vaccine will have access to it,’ Bill Gates tells Gavi fundraiser, as AstraZeneca signs $750M agreement

‘Equal access for all is non-negotiable’ says French prime minister in response

After switching R&D resources to focus on COVID-19, Mariya Gabriel suggests upcoming EU long-term budget will defend €94B earmarked for research from 2021-2027

European Commission helps raise €7.4B to fund global research on vaccines and treatments for COVID-19, but warns this sum represents only a “great start” to funding needed to deal with the pandemic